TcrossGlobal

Tailored Antiplatelet Therapy in High-Risk Patients Undergoing Complex PCI: The TAILORED-CHIP Trial

The TAILORED-CHIP trial demonstrated that in high-ischemic-risk patients undergoing complex PCI, a strategy of potent antiplatelet therapy for the first 6 months followed by de-escalation did not provide a net clinical benefit compared with standard dual antiplatelet therapy (DAPT), according to a study presented by Dr. Duk-Woo Park, Asan Medical Center, Korea, in the Hot Line session at ESC Congress 2025.

In the TAILORED-CHIP trial, 2,018 patients undergoing high-risk PCI were enrolled from 24 hospitals...

Continue reading this article

Select an option below:

Free Registration
Already have an account?
Log In

Introducing the main contents

Conference Reports

Timely delivery of scientific meetings from around the world, including AHA, ESC, TCT, EuroPCR, JCC, etc!

Complex PCI Cases

Features case reports on patients with complex lesions encountered in daily clinical practice.

Live Demonstration CoursesComing soon

In this section you will find live videos of catheter interventions for complex lesions.

What is TCROSS NEWS GLOBAL?

TCROSS NEWS Global, an affiliate of TCROSS Co., Ltd. Japan(established in 2005) is a cardiovascular news website which serves as a link between cardiologists, medical device manufacturers and industry stakeholders.
We provide timely and up-to-date information to our partners across the world by covering and reporting live sessions and conferences, featuring of complex cases, newsletters, academic researches and case studies.

Learn more about TCROSS NEWS Global

This website is automatically translated using Google Translate.